Trade Spyre Therapeutics Inc. - SYRE CFD

Trading Conditions

• Type: CFD
• Spread: 0.1600
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 43.88
• Open: 43.55
• 1-Year Change: 135.28%
• Day's Range: 42.37 - 43.55

What is Spyre Therapeutics Inc. (SYRE)?

Spyre Therapeutics Inc. is a biotechnology company engaged in the development of novel therapies targeting metabolic and liver diseases. The company focuses on advancing treatments for conditions such as non-alcoholic steatohepatitis (NASH) and other related disorders. Its research and development efforts involve the identification and clinical evaluation of drug candidates aimed at addressing underlying disease mechanisms. Spyre Therapeutics operates within the pharmaceutical sector, emphasizing innovation in therapeutic approaches. The company collaborates with various scientific and medical institutions to support its development pipeline. Its organizational structure includes teams dedicated to research, clinical development, and regulatory affairs. Spyre Therapeutics contributes to the broader field of biotechnology by exploring treatments for diseases with significant unmet medical needs.

Spyre Therapeutics Inc. Stock Price Today: Live Overview

The price today is shaped by trading session movements, as Spyre Therapeutics Inc. trades at $43.2100. Price fluctuations have been observed between $42.25 and $43.95, with a daily change percentage of -2.7132%.

FAQ: Spyre Therapeutics Inc. (SYRE)

What is the current price of SYRE stock?

The stock is currently priced at $43.2100.

Does SYRE pay dividends?

No dividends are paid by the company.

Does SYRE have a formal corporate presence or regional headquarters in the UAE?

Spyre Therapeutics Inc. does not have an official office or subsidiary in the UAE and operates through partners and distributors.

What is SYRE best known for?

The company is most famous for its development of novel therapeutics in the pharmaceutical sector.

What assets are typically shown together with SYRE?

Commonly shown alongside SYRE: iShares Emerging Markets Dividend ETF, Nektar, TrueBlue Inc